694 related articles for article (PubMed ID: 10088777)
1. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
2. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
3. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis.
Lohmander LS; Yoshihara Y; Roos H; Kobayashi T; Yamada H; Shinmei M
J Rheumatol; 1996 Oct; 23(10):1765-9. PubMed ID: 8895155
[TBL] [Abstract][Full Text] [Related]
4. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
5. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
[TBL] [Abstract][Full Text] [Related]
6. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
7. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
Ratcliffe A; Beauvais PJ; Saed-Nejad F
J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
[TBL] [Abstract][Full Text] [Related]
8. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
Lohmander LS
J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
[TBL] [Abstract][Full Text] [Related]
9. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
10. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.
Aurich M; Squires GR; Reiner A; Mollenhauer JA; Kuettner KE; Poole AR; Cole AA
Arthritis Rheum; 2005 Jan; 52(1):112-9. PubMed ID: 15641059
[TBL] [Abstract][Full Text] [Related]
11. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.
Lohmander LS; Saxne T; Heinegård DK
Ann Rheum Dis; 1994 Jan; 53(1):8-13. PubMed ID: 8311563
[TBL] [Abstract][Full Text] [Related]
12. Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus.
Lohmander LS; Roos H; Dahlberg L; Hoerrner LA; Lark MW
J Orthop Res; 1994 Jan; 12(1):21-8. PubMed ID: 8113939
[TBL] [Abstract][Full Text] [Related]
13. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
[TBL] [Abstract][Full Text] [Related]
14. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.
Céleste C; Ionescu M; Robin Poole A; Laverty S
J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481
[TBL] [Abstract][Full Text] [Related]
15. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo.
Robion FC; Doizé B; Bouré L; Marcoux M; Ionescu M; Reiner A; Poole AR; Laverty S
J Orthop Res; 2001 Mar; 19(2):250-8. PubMed ID: 11347698
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation.
Chockalingam PS; Glasson SS; Lohmander LS
Osteoarthritis Cartilage; 2013 Feb; 21(2):339-45. PubMed ID: 23142724
[TBL] [Abstract][Full Text] [Related]
17. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
18. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis.
Lorenzo P; Bayliss MT; Heinegård D
Matrix Biol; 2004 Oct; 23(6):381-91. PubMed ID: 15533759
[TBL] [Abstract][Full Text] [Related]
19. Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis.
Laverty S; Ionescu M; Marcoux M; Bouré L; Doizé B; Poole AR
J Orthop Res; 2000 May; 18(3):399-405. PubMed ID: 10937626
[TBL] [Abstract][Full Text] [Related]
20. Cartilage metabolism in the injured and uninjured knee of the same patient.
Dahlberg L; Roos H; Saxne T; Heinegård D; Lark MW; Hoerrner LA; Lohmander LS
Ann Rheum Dis; 1994 Dec; 53(12):823-7. PubMed ID: 7864691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
